Patent details

EP3252161 Title: GENE THERAPY FOR LYSOSOMAL STORAGE DISEASES

Basic Information

Publication number:
EP3252161
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP171681893
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
GENE THERAPY FOR LYSOSOMAL STORAGE DISEASES
French Title of Invention:
THÉRAPIE GÉNIQUE POUR LES MALADIES DE STOCKAGE LYSOSOMAL
German Title of Invention:
GENTHERAPIE FÜR LYOSOMALE SPEICHERERKRANKUNGEN
SPC Number:

Dates

Filing date:
02/06/2008
Grant date:
17/11/2021
EP Publication Date:
06/12/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
17/11/2021
EP B1 Publication Date:
17/11/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/06/2022
Expiration date:
02/06/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
10/11/2021
 
 

Name:
Genzyme Corporation
Address:
50 Binney Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:
CHENG, Seng
Address:
United States (US)

2

Name:
DODGE, James
Address:
United States (US)

Priority

Priority Number:
924947 P
Priority Date:
06/06/2007
Priority Country:
United States (US)

Classification

IPC classification:
C12N 15/86; A61K 48/00; A61K 38/47; A61P 3/00;

Publication

European Patent Bulletin

Issue number:
202146
Publication date:
17/11/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages